Zhang Feng, a prominent China-born biologist and professor at the Massachusetts Institute of Technology (MIT), has been awarded the National Medal of Technology and Innovation on January 10, 2025. This prestigious award recognizes his pivotal role in developing the CRISPR-Cas9 gene-editing technology, which has revolutionized genetic research and has significant applications in agriculture and health [63a0caa4].
The award was presented at the White House by Arati Prabhakar, underscoring the importance of Zhang's contributions to science and innovation. The CRISPR-Cas9 technology has been instrumental in advancing treatments for various diseases, including sickle cell disease, cancer, and type 1 diabetes, marking a significant leap forward in medical science [63a0caa4].
Zhang's recognition adds to the growing list of accolades for scientists of Chinese origin making impactful contributions in the United States. Earlier, Chen Zhijian was awarded the 2024 Albert Lasker Award for Basic Medical Research for his discovery of the enzyme cGAS, which plays a crucial role in the immune response to pathogens. Chen's achievement highlights the ongoing contributions of scientists in understanding immune responses, with implications for cancer and infectious diseases [4cd09426].
Both Zhang and Chen's recognitions reflect the vital role of innovative research in addressing global health challenges and the importance of diverse perspectives in the scientific community. As the Lasker Awards ceremony approaches, where Chen will be honored on September 22, 2024, the spotlight on these scientists emphasizes the transformative power of research and technology in improving human health [4cd09426].